Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease

Related Experiment Video

Updated: Sep 30, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Nele Sigurs1

  • 1Department of Pediatrics, Borås Central Hospital, Borås, Sweden. nele.sigurs@telia.com

Respiratory Research
|July 18, 2002
PubMed

Insights

Respiratory syncytial virus (RSV) bronchiolitis in infancy is linked to later reactive airway disease, especially after severe illness. Preventing RSV may reduce childhood asthma incidence.

Area of Science:

  • Pediatric respiratory health
  • Infectious disease epidemiology
  • Allergy and immunology

Background:

  • Asthma is a major global child health concern.
  • Respiratory syncytial virus (RSV) bronchiolitis is a common infant illness.
  • The link between RSV bronchiolitis and later respiratory issues requires further investigation.

Purpose of the Study:

  • To review evidence associating infant RSV bronchiolitis with subsequent reactive airway disease and allergic sensitization.
  • To identify factors influencing the relationship between RSV bronchiolitis and asthma development.

Main Methods:

  • Review of controlled retrospective and prospective studies.
  • Analysis of associations between RSV bronchiolitis and later respiratory symptoms.
  • Consideration of genetic and environmental risk factors.

Main Results:

  • A significant link exists between RSV bronchiolitis and bronchial obstructive symptoms.
  • The association is strongest in children with severe RSV illness requiring hospitalization.
  • The roles of genetic predisposition and environmental factors remain unclear.

Conclusions:

  • Infant RSV bronchiolitis is associated with an increased risk of developing asthma.
  • Further research, including randomized controlled trials of RSV prevention, is needed.
  • Preventing RSV bronchiolitis could potentially reduce childhood asthma rates.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...